A core of kinase-regulated interactomes defines the neoplastic MDSC lineage

scientific article

A core of kinase-regulated interactomes defines the neoplastic MDSC lineage is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.18632/ONCOTARGET.4746
P932PMC publication ID4694980
P698PubMed publication ID26320174
P5875ResearchGate publication ID280384668

P50authorGrazyna KochanQ28037218
Stefan KnappQ40296391
Hugo ArasanzQ57570957
María Isabel ZudaireQ73670801
Joaquín Fernández-IrigoyenQ79802305
David Guerrero-SetasQ84440422
P2093author name stringNoelia Casares
Apirat Chaikuad
David Escors
Enrique Santamaría
Therese Liechtenstein
Teresa Lozano
Idoia Blanco-Luquin
Maria Gato-Cañas
Xabier Martinez de Morentin
P2860cites workProinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cellsQ24658240
PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cellsQ28242808
Coordinated regulation of myeloid cells by tumoursQ28395157
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationQ29547200
STRING v9.1: protein-protein interaction networks, with increased coverage and integrationQ29614691
Andromeda: a peptide search engine integrated into the MaxQuant environmentQ29615816
Characterization of the MDSC proteome associated with metastatic murine mammary tumors using label-free mass spectrometry and shotgun proteomicsQ33996767
Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and functionQ34087816
The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cellsQ34310345
Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models.Q34326806
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in miceQ34365909
Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assaysQ34456201
Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosisQ34616787
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunityQ34654430
Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancerQ34956969
Classification of current anticancer immunotherapiesQ35149637
Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing miceQ35648172
Inhibition of PPARγ in myeloid-lineage cells induces systemic inflammation, immunosuppression, and tumorigenesisQ35651689
Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancerQ35828574
Proapoptotic BID is required for myeloid homeostasis and tumor suppressionQ35963747
Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancerQ36544980
Effects of notch signaling on regulation of myeloid cell differentiation in cancerQ37456808
Selective activation of intracellular signalling pathways in dendritic cells for cancer immunotherapy.Q37894790
A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics.Q38959137
Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterpartsQ39103952
MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN.Q39356550
Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritisQ39641093
Targeting dendritic cell signaling to regulate the response to immunizationQ40027559
Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacyQ42124738
Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cellsQ42840029
Assessing T-cell responses in anticancer immunotherapy: Dendritic cells or myeloid-derived suppressor cells?Q42910288
Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma modelQ43243177
Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.Q44419395
Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytesQ45866161
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.Q54421148
P4510describes a project that useslimmaQ112236343
RTCAQ114077291
P433issue29
P407language of work or nameEnglishQ1860
P304page(s)27160-27175
P577publication date2015-07-23
P1433published inOncotargetQ1573155
P1476titleA core of kinase-regulated interactomes defines the neoplastic MDSC lineage
P478volume6

Reverse relations

cites work (P2860)
Q50041869Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.
Q90300272Decoding communication patterns of the innate immune system by quantitative proteomics
Q65000057ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer.
Q47550777Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections.
Q40385399Myeloid-Derived Suppressor Cells
Q48293607Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
Q48215791Myeloid-derived suppressor cells coming of age.
Q47563950Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
Q38824190Novel immunotherapies for the treatment of melanoma.
Q64085542PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
Q40062424PD1 signal transduction pathways in T cells.
Q88081063Plasticity of myeloid-derived suppressor cells in cancer
Q92285420Radiopotentiation of enzalutamide over human prostate cancer cells as assessed by real-time cell monitoring
Q92132117Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
Q64914890The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer.
Q57067759The intracellular signalosome of PD-L1 in cancer cells
Q47103744The paradoxical role of tumor-infiltrating immune cells in lung cancer
Q89587297Translational Landscape of mTOR Signaling in Integrating Cues Between Cancer and Tumor Microenvironment
Q92787500Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment

Search more.